Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

The Top 3 Best Places to Work in Indonesia for 2022 revealed

JAKARTA, Indonesia, Dec. 27, 2022 /PRNewswire/ -- Novo Nordisk, AstraZeneca and Jardine Schindler Indonesia are recognized as the top 3 best places to work in Indonesia for 2022 according to the annual prestigious "Best Places to Work" certification program. Best Places to Work is an international...

2022-12-27 21:39 2385

Waterdrop Listed among Beijing's Top 100 Enterprises in Digital Economy

BEIJING, Dec. 27, 2022 /PRNewswire/ -- Recently, Beijing Enterprise Confederation and Beijing Entrepreneurs Association released the Top 100 Enterprises inBeijing list (the List) and the Report on the Development of the Top 100 Enterprises inBeijing (the Report) at the Beijing International Conv...

2022-12-27 21:00 2711

Promising Singaporean Medtech Firm Osteopore Achieves Record Revenue, Enters New Markets and Operates in All Major Continents in 2022

SINGAPORE, Dec. 27, 2022 /PRNewswire/ -- Singapore-based Medtech Firm Osteopore announces their record revenue of$460,684 for Q3 CY22, an increase of 6.6% over the preceding quarter. As an extension of the same financial year, Osteopore has likewise broadened their regional operations to spanColo...

2022-12-27 20:37 3047

Brii Biosciences Provides Update on Strategic Clinical Development Progress

Topline Phase 2 data from multiple hepatitis B viral (HBV) infection functional cure combination studies expected in the first half of 2023 Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment U.S. FDA lifted clinical hol...

2022-12-27 20:00 2779

China to downgrade COVID-19 management to Class B

BEIJING, Dec. 27, 2022 /PRNewswire/ -- A report from People's Daily: China will downgrade management of COVID-19 to Class B and cancel quarantine requirements on inbound travelers fromJan. 8, 2023, China's top health authority announced recently. In a statement released late Monday, the National...

2022-12-27 18:06 2267

EOFlow Submits Application to the U.S. FDA for its Wearable Insulin Pump 'EOPatch'

* Plans to finalize its U.S. distribution strategy in 2023 * Aims to enter the U.S., the world's largest diabetes market, with its current disposable wearable insulin pump 'EOPatch' SAN JOSE, Calif. , Dec. 27, 2022 /PRNewswire/ -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a p...

2022-12-27 15:48 1763

Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification

* Hetero's 'Nirmacom' (Nirmatrelvir), a generic version of Pfizer's COVID-19 oral antiviral drug 'PAXLOVID' is co-packaged with ritonavir tablets * With the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs including India HYDERABAD, India, Dec. 27, ...

2022-12-27 10:00 3384

Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies

SHANGHAI, Dec. 27, 2022 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze") announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co., Ltd. ("Yonghe") to develop series of targeted radiopharmaceutical therapy ("TRT") products. Under the...

2022-12-27 10:00 2570

GeneQuantum and WuXi XDC Entered into Strategic Collaboration to Empower Innovative Bioconjugate Development

SUZHOU, China, Dec. 26, 2022 /PRNewswire/ -- GeneQuantum Healthcare (GQ), a global innovative biotechnology company dedicated to the development of the next generation bioconjugate drugs , and WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), ann...

2022-12-26 23:01 2512

MindRank Announces U.S. FDA Clearance of IND Application for MDR-001, a Novel GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes and Obesity

SHANGHAI and HANGZHOU, China, Dec. 26, 2022 /PRNewswire/ -- MindRank, an artificial intelligence (AI)-empowered drug discovery company, announces today that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for MDR-001, an oral sma...

2022-12-26 23:00 2492

CJ CheilJedang, and Emmyon, Inc. sign a Licensing Agreement to commercialize a dietary supplement with natural extracts for use in significant improvement of skeletal muscle mass and function in humans.

SEOUL, South Korea and ROCHESTER, Minn., Dec. 26, 2022 /PRNewswire/ -- CJ Food and Nutrition Tech (CJ FNT), a newly formed business unit of CJ CheilJedang, a South Korea based global food and nutrition company, and Emmyon, Inc., a privately-held biotechnology start-up company based inRochester, MN...

2022-12-26 21:00 2784

CJ CheilJedang, and Emmyon, Inc. sign a Licensing Agreement to commercialize a dietary supplement with natural extracts for use in significant improvement of skeletal muscle mass and function in humans.

In Vitro Fertilization Services Industry to be Boosted by Innovative Technologies

Global IVF services market is expected to reach $43.97 billion by 2027, registering growth at a CAGR of 20.46% SAN ANTONIO, Dec. 26, 2022 /PRNewswire/ -- In vitro fertilization (IVF), one type of assisted reproductive technology (ART), is becoming more popular due to an increase in infertility r...

2022-12-26 16:12 2547

In Vitro Fertilization Services Industry to be Boosted by Innovative Technologies

China actively optimizes COVID-19 response measures to better prepare for challenges

BEIJING, Dec. 26, 2022 /PRNewswire/ -- As multiple regions in China have seen surging COVID-19 infections, local governments are taking swift and precise measures to prevent severe cases, protect people's health, and build a barrier against the epidemic. These measures include providing timely m...

2022-12-26 14:32 3172

Superior Neutralizing Antibody Titer Levels Against Omicron BF.7 And BA.2.75 Of The Company's Two-Component Recombinant COVID-19 Vaccine ReCOV As Compared To International Mainstream mRNA Vaccine

TAIZHOU, China, Dec. 26, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that positive results were achieved for its sequential booster vaccination Phase II study of the recombinant two-component COVID-19...

2022-12-26 11:33 4043

Pulnovo Medical will be attending JPM Healthcare Conference 2023

SHANGHAI, Dec. 24, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovative platform, will be attending the upcoming 41st J.P. Morgan Healthcare Conference 2023 to discuss the latest trends in innovative technologies and development strategies in the medical device secto...

2022-12-24 20:00 3728

AAHRPP Accredits Three More Research Organizations, Including First Hospital in Japan

Twelve earn accreditation in 2022, returning to pre-COVID-19 levels WASHINGTON, Dec. 23, 2022 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs has accredited three more research organizations, including the first hospital inJapan, the flagship universit...

2022-12-23 20:25 2855

Hyphens Pharma licenses Winlevi® for all 10 ASEAN countries from Cosmo Pharmaceuticals

* Winlevi® is a first-in-class topical drug for the treatment of acne approved by U.S. FDA inAugust 2020. * It will reinforce our Proprietary Brand segment's dermatological franchise. SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- Hyphens Pharma International Limited (" Hyphens Pharma", or the "Comp...

2022-12-23 17:00 1853

PVmed Raises US $14 Million Series A Funding from Cherami, Philips, JHF, COCOCAPITAL, and Strategy Capital

Will Support Rapid Expansion of PVmed's AI Cancer Treatment Product Portfolio GUANGZHOU, China, Dec. 22, 2022 /PRNewswire/ -- Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered inGuangzhou, China, has secured US ...

2022-12-23 11:31 2137

JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL

Best Cell & Gene Therapy Acquisition 2022: Juniper Biologics/Kolon Life Science SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd , a science-led healthcare company focused on commercialising novel therapies, was awarded ...

2022-12-23 09:35 2920

Antengene Announces NDA Submission for XPOVIO® in Macau, Malaysia and Thailand for Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-cell Lymphoma

SHANGHAI and HONG KONG, Dec. 23, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hem...

2022-12-23 08:30 2824

1 ... 217 218 219220221 222 223 ... 808